Company Monitoring Page for UCB-Pharma

latest headlines for company on cafepharma

Amgen, UCB are back pitching once-rejected osteoporosis drug romo to the FDA — but big hurdles lie ahead
Endpoints
Fri, 07/13/18 - 11:57 am
Tags:
Amgen, UCB Pharma, osteoporosis, romosozumab
US approves UCB’s Cimzia for psoriasis
Pharma Times
Tue, 05/29/18 - 09:16 pm
Tags:
FDA, UCB Pharma, Cimzia, psoriasis
Briviact (Brivaracetam) Wins Approval to Treat Partial-Onset (Focal) Seizures in Pediatric Epilepsy Patients
CP Wire
Mon, 05/14/18 - 09:40 am
Tags:
UCB Pharma, FDA, Briviact, partial onset seizures, epilepsy, pediatric epilepsy
UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis
CP Wire
Sat, 04/28/18 - 11:56 am
Tags:
UCB Pharma, CHMP, Cimzia, psoriasis
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
Tags:
AbbVie, Allergan, Roche, Biogen, UCB Pharma, Acorda Therapeutics, M&A
Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report
Endpoints
Fri, 01/19/18 - 11:15 am
Tags:
Biogen, UCB Pharma, Acorda Therapeutics, M&A
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Yahoo/Zacks.com
Sat, 11/25/17 - 12:29 pm
Tags:
Nektar, AstraZeneca, Movantik, Onzeald, UCB Pharma, Cimzia, Amgen, Neulasta
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Sat, 09/2/17 - 11:11 am
Tags:
Parkinson's Disease, Novartis, Teva Pharmaceutial, UCB Pharma, MEDI1341, AstraZeneca, Takeda, PRX002, Prothena, Roche, Acorda, Inbrija, Adamas Pharmaceuticals, Gocovri
FDA rejects Amgen’s osteoporosis drug romo as rival Radius surprises with a new CEO
Endpoints
Mon, 07/17/17 - 09:15 am
Tags:
FDA, Amgen, osteoporosis, romosozumab, UCB Pharma, Radius Health, Tymlos
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Fierce Pharma
Mon, 05/22/17 - 09:45 am
Tags:
Amgen, romosozumab, Radius Health, UCB Pharma, Tymlos, osteoporosis
UCB’s Cimzia AutoClicks pen hits the U.K. market
Mass Device
Wed, 10/26/16 - 08:54 am
Tags:
UCB Pharma, Cimzia, UK, devices, rheumatoid arthritis, Cimzia AutoClick
Drugmakers revive R&D focus on long stagnant women's health market
Medical Marketing and Media
Tue, 08/23/16 - 10:50 am
Tags:
R&D, Women's Health, innovation, Myovant Sciences, Amgen, UCB Pharma, breast cancer, Pfizer, S1 Biopharma, Ibrance, Addyi
7 big pharma companies sign on to Parkinson's development group
BioPharma Dive
Wed, 02/24/16 - 11:49 am
Tags:
R&D, AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Pfizer, UCB Pharma, Parkinson's Disease
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Yahoo/Reuters
Mon, 02/22/16 - 09:40 am
Tags:
Amgen, UCB Pharma, osteoporosis, clinical trials, romosozumab
FDA approves UCB drug for treating epileptic seizures
Fierce Pharma
Fri, 02/19/16 - 11:09 am
Tags:
FDA, UCB Pharma, epilepsy, seizures, Briviact
Why UCB isn't afraid of social media
Medical Marketing and Media
Mon, 11/9/15 - 09:45 pm
Tags:
UCB Pharma, social media
Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases
Forbes
Wed, 10/14/15 - 02:15 pm
Tags:
FCPA, bribery, GSK, Bristol-Myers Squibb, Teva Pharmaceutical, Sanofi, AstraZeneca, UCB Pharma, Novartis, Novo Nordisk, Eli Lilly
Lannett Buys UCB's U.S. Generics Division for $1.23 Billion
Bloomberg
Wed, 09/2/15 - 05:15 pm
Tags:
Lannett, UCB Pharma, generics, M&A
UCB's lupus trial fails in final clinical tests
Yahoo/Reuters
Tue, 07/28/15 - 10:01 am
Tags:
UCB Pharma, lupus, epratuzumab
UCB reportedly gets bids for Kremers Urban unit from Cipla and Lupin
Fierce Pharma
Mon, 06/1/15 - 07:12 pm
Tags:
UCB Pharma, Cipla, M&A, Kremers Urban Pharmaceuticals, Lupin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.